Improving effect of chronic resveratrol treatment on central monoamine synthesis and cognition in aged rats

Age

Volumn 37, Issue 3, 2015, Pages

  Sarubbo, F ^a   Ramis, M R ^a   Aparicio, S ^a   Ruiz, L ^a   Esteban, S ^a   Miralles, A ^a   Moranta, D ^a,b  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Aging; Brain; Cognition; Monoamine synthesis; Resveratrol

Indexed keywords

DOPAMINE; NORADRENALIN; RESVERATROL; SEROTONIN; TYROSINE 3 MONOOXYGENASE; STILBENE DERIVATIVE; TRYPTOPHAN HYDROXYLASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE SYNTHESIS; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; ENZYME ACTIVITY; HIPPOCAMPUS; IN VIVO STUDY; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MONOAMINE METABOLISM; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PINEAL BODY; RADIAL ARM MAZE TEST; RAT; WORKING MEMORY; ANIMAL; BODY TEMPERATURE; BODY WEIGHT; BRAIN; COGNITION; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; WISTAR RAT;

AGING; ANIMALS; BODY TEMPERATURE; BODY WEIGHT; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION; MALE; RATS; RATS, WISTAR; STILBENES; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE;

EID: 84929500935     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-015-9777-x     Document Type: Article

References (55)

1. Adams W, Kusljic S, Van den Buuse M (2008) Serotonin depletion in the dorsal and ventral hippocampus: effects on locomotor hyperactivity, prepulse inhibition and learning and memory. Neuropharmacology 55:1048–1055
2. Albani D, Polito L, Signorini A, Forloni G (2010) Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36:370–376
3. Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305:1010–1013
4. Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, Shen HF, Xie LP (2010) Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci 101:488–493
5. Baur JA (2010) Biochemical effects of SIRT1 activators. Biochim Biophys Acta 1804:1626–1634
6. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493–506
7. Blanchet J, Longpré F, Bureau G, Morissette M, DiPaolo T, Bronchti G, Martinoli MG (2008) Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 32:1243–1250
8. Borella E, Carretti B, De Beni R (2008) Working memory and inhibition across the adult life-span. Acta Psychol (Amst) 128:33–44
9. Butterfield DA, Abdul HM, Newman S, Reed T (2006) Redox proteomics in some age-related neurodegenerative disorders or models thereof. NeuroRx 3:344–357
10. Cash CD (1998) Why tryptophan hydroxylase is difficult to purify: a reactive oxygen-derived species-mediated phenomenon that may be implicated in human pathology. Gen Pharmacol 30:569–574
11. Chen LW, Wang YQ, Wei LC, Shi M, Chan YS (2007) Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson’s disease. CNS Neurol Disord Drug Targets 6:273–281
12. Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32:591–601
13. Collier TJ, Greene JG, Felten DL, Stevens SY, Collier KS (2004) Reduced cortical noradrenergic neurotransmission is associated with increased neophobia and impaired spatial memory in aged rats. Neurobiol Aging 25:209–221
14. Cools R (2011) Dopaminergic control of the striatum for high-level cognition. Curr Opin Neurobiol 21:402–407
15. De La Cruz CP, Revilla E, Venero JL, Ayala A, Cano J, Machado A (1996) Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rat. Free Radic Biol Med 20:53–61
16. Dias CP, De Lima MN, Torres JP, Dormelles A, Garcia VA, Scalco F, Guimarães M, Constantino L, Budni P, Dal-Pizzol F, Schöder N (2007) Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats. Neuroscience 146:1719–1725
17. Donmez G, Wang D, Cohen DE, Guarente L (2010) SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142:320–332
18. Esteban S, Garau C, Aparicio S, Moranta D, Barceló P, Fiol MA, Rial R (2010a) Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain. J Pineal Res 48:170–177
19. Esteban S, Garau C, Aparicio S, Moranta D, Barceló P, Ramis M, Tresguerres JA, Rial R (2010b) Improving effects of long-term growth hormone treatment on monoaminergic neurotransmission and related behavioral tests in aged rats. Rejuvenation Res 13:707–716
20. Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L, Mak G, Kim D, Su SC, Tsai LH (2010) A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466:1105–1109
21. Gareri P, De Fazio P, De Sarro G (2002) Neuropharmacology of depression in aging and age-related diseases. Ageing Res Rev 1:113–134
22. González-Burgos I, Feria-Velasco A (2008) Serotonin/dopamine interaction in memory formation. Prog Brain Res 172:603–623
23. Guarente L, Franklin H (2011) Epstein lecture: sirtuins aging, and medicine. N Engl J Med 364:2235–2244
24. Haider S, Saleem S, Perveen T, Tabassum S, Batool Z, Sadir S, Liaquat L, Madiha S (2014) Age-related learning and memory deficits in rats: role of altered brain neurotransmitters, acetylcholinesterase activity and changes in antioxidant defense system. Age 36:1291–1302
25. Hedden T, Gabrieli JD (2004) Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 5:87–96
26. Hussain AM, Mitra AK (2000) Effect of aging on tryptophan hydroxylase in rat brain: implications on serotonin level. Drug Metab Dispos 28:1038–1042
27. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64:1152–1156
28. Kemp A, Manahan-Vaughan D (2008) Beta-adrenoreceptors comprise a critical element in learning-facilitated long-term plasticity. Cereb Cortex 18:1326–1334
29. Koprowska M, Krotewicz M, Romaniuk A, Strzelczuk M (2004) Age-related changes in fear behavior and regional brain monoamines distribution in rats. Acta Neurobiol Exp (Wars) 64:131–142
30. Kumar A, Naidu PS, Seghal N, Padi SS (2007) Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79:17–26
31. Lemon N, Manahan-Vaughan D (2006) Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression. J Neurosci 26:7723–7729
32. Li J, Feng L, Xing Y, Wang Y, Du L, Xu C, Cao J, Wang Q, Fan S, Liu Q, Fan F (2014) Radioprotective and antioxidant effect of resveratrol in hippocampus by activating Sirt1. Int J Mol 15:5928–5939
33. Lofrumento DD, Nicolardi G, Cianciulli A, De Nuccio F, La Pesa V, Carofiglio V, Dragone T, Calvello R, Panaro MA (2014) Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson’s-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. Innate Immun 20:249–260
34. Luine V, Bowling D, Hearns M (1990) Spatial memory deficits in aged rats: contributions of monoaminergic systems. Brain Res 537:271–278
35. Meneses A (1999) 5-HT system and cognition. Neurosci Biobehav Rev 23:1111–1125
36. Míguez JM, Aldegunde M, Paz-Valiñas L, Recio J, Sánchez-Barceló E (1999) Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging. J Neural Transm 106:1089–1098
37. Moranta D, Esteban S, García-Sevilla JA (2009) Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain. Naunyn Schmiedebergs Arch Pharmacol 379:61–72
38. Moranta D, Barceló P, Aparicio S, Garau C, Sarubbo F, Ramis M, Nicolau C, Esteban S (2014) Intake of melatonin increases tryptophan hydroxylase type 1 activity in aged rats: Preliminary study. Exp Gerontol 49:1–4
39. Morrison AB, Chein JM (2011) Does working memory training work? The promise and challenges of enhancing cognition by training working memory. Psychon Bull Rev 18:46–60
40. Murchison CF, Zhang XY, Zhang WP, Ouyang M, Lee A, Thomas SA (2004) A distinct role for norepinephrine in memory retrieval. Cell 117:131–143
41. Park DC, Lautenschlager G, Hedden T, Davidson NS, Smith AD, Smith PK (2002) Models of visuospatial and verbal memory across the adult life span. Psychol Aging 17:299–320
42. Payer D, Marshuetz C, Sutton B, Hebrank A, Welsh RC, Park DC (2006) Decreased neural specialization in old adults on a working memory task. Neuroreport 17:487–491
43. Ramis M, Sarubbo F, Sola J, Aparicio S, Garau C, Miralles A, Esteban S (2013) Cognitive improvement by acute growth hormone is mediated by NMDA and AMPA receptors and MEK pathway. Prog Neuropsychopharmacol Biol Psychiatry 45:11–20
44. Ranney A, Petro MS (2009) Resveratrol protects spatial learning in middle-aged C57BL/6 mice from effects of ethanol. Behav Pharmacol 20:330–336
45. Rose KM, Parmar MS, Cavanaugh JE (2014) Dietary supplementation with resveratrol protects against striatal dopaminergic deficits produced by in utero LPS exposure. Brain Res 1573:37–43
46. Shipstead Z, Redick TS, Engle RW (2010) Does working memory training generalize? Psychol Belg 50:245–276
47. Takeuchi H, Taki Y, Kawashima R (2010) Effects of working memory training on cognitive functions and neural systems. Rev Neurosci 21:427–449
48. Tredici G, Miloso M, Nicolini G, Galbiati S, Cavaletti G, Bertelli A (1999) Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant? Drugs Exp Clin Res 25:99–103
49. Tsunemi A, Utsuyama M, Seidler BK, Kobayashi S, Hirokawa K (2005) Age-related decline of brain monoamines in mice is reversed to young level by Japanese herbal medicine. Neurochem Res 30:75–81
50. Turner PV, Brabb T, Pekow C, Vasbinder MA (2011) Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50:600–613
51. Venero JL, Machado A, Cano J (1991) Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats. J Neurochem 56:1940–1948
52. Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader M (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76
53. Wang Y, Xu H, Fu Q, Ma R, Xiang J (2011) Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian rats. J Neurol Sci 304:29–34
54. Xu Y, Wang Z, You W, Zhang X, Li S, Barish PA, Vernon MM, Du X, Li G, Pan J, Ogle WO (2010) Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline System. Eur Neuropsychopharmacol 20:405–413
55. Yañez M, Fraiz N, Cano E, Orallo E (2006) Inhibitory effects of cis- and transresveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem Biofis Res Commun 344:688–695